294 related articles for article (PubMed ID: 27973767)
21. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
Shahbazi R; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
[TBL] [Abstract][Full Text] [Related]
22. Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering.
Shariati L; Esmaeili Y; Rahimmanesh I; Babolmorad S; Ziaei G; Hasan A; Boshtam M; Makvandi P
Environ Res; 2023 Dec; 238(Pt 1):116933. PubMed ID: 37652218
[TBL] [Abstract][Full Text] [Related]
23. Nanomedicine, an emerging therapeutic strategy for oral cancer therapy.
Marcazzan S; Varoni EM; Blanco E; Lodi G; Ferrari M
Oral Oncol; 2018 Jan; 76():1-7. PubMed ID: 29290280
[TBL] [Abstract][Full Text] [Related]
24. Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer.
Gupta U; Saren BN; Khaparkhuntikar K; Madan J; Singh PK
J Control Release; 2022 Aug; 348():1089-1115. PubMed ID: 35640765
[TBL] [Abstract][Full Text] [Related]
25. Dendrimers for theranostic applications.
Sk UH; Kojima C
Biomol Concepts; 2015 Jun; 6(3):205-17. PubMed ID: 26136305
[TBL] [Abstract][Full Text] [Related]
26. HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches.
Colombo M; Corsi F; Foschi D; Mazzantini E; Mazzucchelli S; Morasso C; Occhipinti E; Polito L; Prosperi D; Ronchi S; Verderio P
Pharmacol Res; 2010 Aug; 62(2):150-65. PubMed ID: 20117211
[TBL] [Abstract][Full Text] [Related]
27. Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases.
Kim KS; Song CG; Kang PM
Antioxid Redox Signal; 2019 Feb; 30(5):733-746. PubMed ID: 29228781
[TBL] [Abstract][Full Text] [Related]
28. Graphene-based multifunctional nanosystems for simultaneous detection and treatment of breast cancer.
Dolatkhah M; Hashemzadeh N; Barar J; Adibkia K; Aghanejad A; Barzegar-Jalali M; Omidi Y
Colloids Surf B Biointerfaces; 2020 Sep; 193():111104. PubMed ID: 32417466
[TBL] [Abstract][Full Text] [Related]
29. Nanotechnology in inflammation: cutting-edge advances in diagnostics, therapeutics and theranostics.
Liu Y; Lin Z; Wang Y; Chen L; Wang Y; Luo C
Theranostics; 2024; 14(6):2490-2525. PubMed ID: 38646646
[TBL] [Abstract][Full Text] [Related]
30. Applications of Nanoparticles Probes for Prostate Cancer Imaging and Therapy.
Gao T; Bi A; Yang S; Liu Y; Kong X; Zeng W
Adv Exp Med Biol; 2018; 1096():99-115. PubMed ID: 30324350
[TBL] [Abstract][Full Text] [Related]
31. Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds.
Rivera Gil P; Hühn D; del Mercato LL; Sasse D; Parak WJ
Pharmacol Res; 2010 Aug; 62(2):115-25. PubMed ID: 20097288
[TBL] [Abstract][Full Text] [Related]
32. Functional nanoplatforms for enhancement of chemotherapeutic index.
Yang J; Lee E; Ku M; Huh YM; Cheong JH
Anticancer Agents Med Chem; 2013 Feb; 13(2):212-21. PubMed ID: 22934694
[TBL] [Abstract][Full Text] [Related]
33. Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer.
Rajana N; Mounika A; Chary PS; Bhavana V; Urati A; Khatri D; Singh SB; Mehra NK
J Control Release; 2022 Dec; 352():1024-1047. PubMed ID: 36379278
[TBL] [Abstract][Full Text] [Related]
34. Antibody-targeted nanoparticles for cancer treatment.
Carter T; Mulholland P; Chester K
Immunotherapy; 2016 Jul; 8(8):941-58. PubMed ID: 27381686
[TBL] [Abstract][Full Text] [Related]
35. Toxicity of inorganic nanomaterials in biomedical imaging.
Li J; Chang X; Chen X; Gu Z; Zhao F; Chai Z; Zhao Y
Biotechnol Adv; 2014; 32(4):727-43. PubMed ID: 24389087
[TBL] [Abstract][Full Text] [Related]
36. Unique roles of nanotechnology in medicine and cancer.
Alam F; Naim M; Aziz M; Yadav N
Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179
[TBL] [Abstract][Full Text] [Related]
37. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
[TBL] [Abstract][Full Text] [Related]
38. Nanomedicine applied to translational oncology: A future perspective on cancer treatment.
Bregoli L; Movia D; Gavigan-Imedio JD; Lysaght J; Reynolds J; Prina-Mello A
Nanomedicine; 2016 Jan; 12(1):81-103. PubMed ID: 26370707
[TBL] [Abstract][Full Text] [Related]
39. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
Sharma R; Mody N; Agrawal U; Vyas SP
Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
[TBL] [Abstract][Full Text] [Related]
40. Photoacoustic-based nanomedicine for cancer diagnosis and therapy.
Sim C; Kim H; Moon H; Lee H; Chang JH; Kim H
J Control Release; 2015 Apr; 203():118-25. PubMed ID: 25701310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
